Implant Sciences' 13th Patent Foreshadows the Future of Trace Detection Technology
Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has been issued patent # 8,173,959 from the U.S. Patent and Trademark Office. The patent, "Real-Time Trace Detection by High Field and Low Field Ion Mobility and Mass Spectrometry," covers a method for a hyphenated trace detection employing a combination of ion mobility spectrometry, differential mobility spectrometry, and mass spectrometry. This marks the thirteenth patent Implant Sciences has been issued and the third it has received in fiscal 2012.
Implant Sciences' latest patent focuses on the real-time detection, identification and analysis of trace amounts of narcotics, explosives and chemical agents.
Global LiDAR Market 2014-2018
Todd Silvestri, Implant Sciences' Vice President of Technology, stated, "We believe the technology described in this patent will define the next generation of trace detection equipment. Systems incorporating this invention will be able to detect a wider range of threats with greater accuracy and fewer false alarms while maintaining the advantages of IMS throughput."
"Mass Spectrometry has been a promising technology in trace detection for more than a decade," added Implant Sciences' Chief Operating Officer, Dr. Bill McGann. "The time for implementation is now, and the benefits for expanding the range of detection will greatly enhance global security. Turning credible science into practical technology through innovation is a cornerstone of the Implant Sciences global strategy."
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Implant Sciences Corp.